Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 504

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Morbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissection

Open access
Ashikaga, Takamaru, Krag, David N., Land, Stephanie R., Julian, Thomas B., Anderson, Stewart J., Brown, Ann M., Skelly, Joan M., Harlow, Seth P., Weaver, Donald L., Mamounas, Eleftherios P., Costantino, Joseph P., Wolmark, Norman·2010·Journal of Surgical Oncology

Abstract

Background and Objectives: Three year post‐surgical morbidity levels were compared between patients with negative sentinel lymph node dissection alone (SLND) and those with negative sentinel node dissection and negative axillary lymph node dissection (ALND) in the NSABP B‐32 trial. Methods: A total of 1,975 ALND and 2,008 SLND node negative breast cancer patients had shoulder range of motion and arm volumes assessed along with self reports of arm tingling and numbness. Relative shoulder abduction deficits and relative arm volume differences between ipsilateral and contralateral arms were calculated. Results: Shoulder abduction deficits ≥10% peaked at 1 week for the ALND (75%) and SLND (41%) groups. Arm volume differences ≥10% at 36 months were evident for the ALND (14%) and SLND (8%) groups. Numbness and tingling peaked at 6 months for the ALND (49%, 23%) and SLND (15%, 10%) groups. Logistic regression correlates of residual morbidity included treatment group, age, handedness, tumor size, systemic chemotherapy, and radiation to the axilla. Conclusions: Although residual morbidity for both treatment groups was evident, the results of the NSABP B‐32 study indicate the superiority of the SLND compared to the ALND treatment approach relative to post‐surgical morbidity outcomes over a 3‐year follow‐up period. J. Surg. Oncol. 2010;102:111–118. © 2010 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jso.21535

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 504

Metadata

Authors
Ashikaga, T., Krag, D. N., Land, S. R., Julian, T. B., Anderson, S. J., Brown, A. M., Skelly, J. M., Harlow, S. P., Weaver, D. L., Mamounas, E. P., Costantino, J. P., & Wolmark, N.
Venue
Journal of Surgical Oncology
Publisher
Wiley
Published
2010-07-14
Volume
102
Issue
2
Pages
111-118
ISSN
  • 0022-4790 (ISSN-L)
  • 1096-9098
OpenAlex
W1972645288
Cited by
504
References
11
FWCI
9.03
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Morbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissection. https://app.cochat.ai/papers/10.1002/jso.21535
The paper
Ashikaga, T., Krag, D. N., Land, S. R., Julian, T. B., Anderson, S. J., Brown, A. M., Skelly, J. M., Harlow, S. P., Weaver, D. L., Mamounas, E. P., Costantino, J. P., & Wolmark, N. (2010). Morbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissection. Journal of Surgical Oncology. https://doi.org/10.1002/jso.21535

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.